|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 31/16 | (2006.01) | ||
| A61K 31/60 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 2266564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10179026.9 |
| Date of filing the European patent application | 1998-12-22 | |
| (97) | Date of publication of the European application | 2010-12-29 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-13 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (30) | Number | Date | Country code |
| 68480 P | 1997-12-22 | US |
| (72) |
Kaiko, Robert, F., US
Colucci, Robert, D., US
|
| (73) |
Euro-Celtique S.A.,
2, avenue Charles de Gaulle, 1653 Luxembourg,
LU
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė peroralinė vaisto forma apimanti opioido agonisto ir opioido antagonisto derinį |
| Pharmaceutical oral dosage form comprising a combination of an opioid agonist and an opioid antagonist |
| Payment date | Validity (years) | Amount | |
| 2015-12-04 | 18 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2015-11-27 |